Bioactive Composite Material Based on Polyurethane with Isoniazid

Abstract

An urgent task is the development of new implantation materials with a prolonged medicinal effect for the treatment of the extrapulmonary form of tuberculosis. The purpose of this investigation was to obtain an implantation material based on mesh polyurethane with the anti-tuberculosis drug isoniazid, to study the drug release of isoniazid from the polymer, to study the biodegradation of such materials, as well as to analyze cellular reactions to their implantation in the body of experimental animals. According to the results of the study of the dynamics of the release of isoniazid from the structure of mesh polyurethane, it was shown that a little more than 44% of isoniazid was released from the polymer matrix during the 389 days of the study. At the same time, in the first 3 days, a shock dose of the anti-tuberculosis drug was released – more than 18%, which can be important for reducing the pathological process at the location of the implant. When studying the biodegradation of the obtained materials, it was established that there was a redistribution of supramolecular structures, in which the type of these structures remained unchanged, but the size of the globular particles changed. In the model environments, the organization of large, possibly hydrophobic, destruction fragments into large globular formations probably took place, which was reflected in the increase of some physical and mechanical indicators. During implantation, the polymer material was subjected to cellular resorption due to the activity of phagocytic fragments, as well as mechanical loads, which contributed to the removal of destruction products from the mass of the polymer and led to a decrease in the main physical and mechanical parameters. According to the results of the implantation test by histological methods, it was established that around the samples of polyurethane with isoniazid a rather pronounced and long-lasting (up to 1 month) reaction of the type of aseptic inflammation was observed. At the same time, the cellular composition of the connective tissue capsule indicated a fairly good tolerability of the polymer material with prolonged release of isoniazid. It is shown that the obtained bioactive composite material based on polyurethane with isoniazid can be a promising implant material for the treatment of bone and joint tuberculosis.